Diagnosis and Treatment of Patients With Cystic Fibrosis

National Institutes of Health (NIH)

Status: Enrolling

Conditions: Diabetes; Pancreatic Insufficiency (Exocrine and Endocrine); Cystic Fibrosis; Liver Disease or Abnormalities

Study type: Observational

Funder types: NIH

Identifiers

NCT00001223

87-DK-0029

870029

Details and patient eligibility

About

This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis.

Full description

This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis.

Enrollment: 9,999 estimated patients

Sex: All

Ages: 4 to 120 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

• INCLUSION CRITERIA
• Patients with known or suspected CF and family members of patients with CF.
• >=4 years of age

EXCLUSION CRITERIA

-Concomitant medical, psychiatric or other problems which might complicate interpretation of studies of CF, or for which we are unable to provide adequate care.

Trial design

9,999 participants in 2 patient groups

CF Patients

Description:

cystic fibrosis patients

CF Relatives

Description:

relatives of cystic fibrosis patients